4-{[4-(beta-D-Glucopyranosyloxy)benzyl]oxy}-2-(2-{[4-(beta-D-glucopyranosyloxy)benzyl]oxy}-2-oxoethyl)-2-hydroxy-4-oxobutanoic acid(CAS: 174972-80-6)

The compound (CAS: 174972-80-6) is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for health and environmental hazards. Regulated under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) in the EU, it may require notification to the U.S. Environmental Protection Agency (EPA) and compliance with FDA regulations for pharmaceutical applications.

Alternative reagents such as similar glycosylated compounds or simpler derivatives can be used. Isomers and analogs include variations in the glycosylation pattern or substitution of benzyl groups. These alternatives may offer similar functionalities with varying degrees of complexity and cost.

The demand for this compound is driven by its use in pharmaceuticals and biotechnology. Research trends focus on its application in carbohydrate chemistry and drug delivery systems. Market trends show increasing interest in glycosylated compounds due to their potential in personalized medicine and therapeutic applications.

Waste should be collected in sealed containers and disposed of through professional waste disposal services. Incineration is recommended for safe destruction. Environmental precautions include proper containment to prevent spillage and ensure worker safety during handling and disposal. Compliance with local regulations is essential.